| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/01/2002 | CA2436091A1 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 08/01/2002 | CA2435910A1 Oomycete ftsz-mt as a target for antimicrobial-specific biocides |
| 08/01/2002 | CA2435826A1 Differentiation of stem cells to pancreatic endocrine cells |
| 08/01/2002 | CA2435783A1 Method for detection of the presence of prion proteins |
| 08/01/2002 | CA2435781A1 Method for detecting of prions in a sample |
| 08/01/2002 | CA2435776A1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | CA2435612A1 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 08/01/2002 | CA2435610A1 Cytoplasmic gene inhibition or gene expression in transfected plants by a tobraviral vector |
| 08/01/2002 | CA2435510A1 Methods for screening for substances which inhibit fp prostanoid receptor interaction with a compound having pgf2.alpha.alphaactivity and methods of treating cancer |
| 08/01/2002 | CA2435047A1 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | CA2434845A1 Hepatitis c virus replicons and replicon enhanced cells |
| 08/01/2002 | CA2434093A1 Method and apparatus for simultaneous quantification of different radionuclides on the surface of a biological microarray |
| 08/01/2002 | CA2433869A1 Gene for identifying individuals with familial dysautonomia |
| 08/01/2002 | CA2433834A1 Activatable cytolytic or drug delivery peptides and uses thereof |
| 08/01/2002 | CA2433681A1 Sulfatases and methods of use thereof |
| 08/01/2002 | CA2433680A1 Double-stranded rna-mediated gene suppression |
| 08/01/2002 | CA2433227A1 Specific human antibodies for selective cancer therapy |
| 08/01/2002 | CA2432991A1 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 08/01/2002 | CA2432346A1 Genome-wide location and function of dna binding proteins |
| 08/01/2002 | CA2432276A1 Regulation of cell growth by muc1 |
| 08/01/2002 | CA2432134A1 Adenylate cyclases |
| 08/01/2002 | CA2431522A1 Isolated nucleic acid molecules encoding a human and mouse g protein-coupled receptor - gpr54; encoded proteins, cells transformed therewith and uses thereof |
| 08/01/2002 | CA2431517A1 Polynucleotides encoding cellular transporters and methods of use thereof |
| 08/01/2002 | CA2431493A1 Aminoacyl trna synthetases |
| 08/01/2002 | CA2431313A1 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 08/01/2002 | CA2431177A1 Trem-1 splice variant for use in modifying immune responses |
| 08/01/2002 | CA2431144A1 Cell adhesion proteins |
| 08/01/2002 | CA2430839A1 Specific mucin expression as a marker for pancreatic cancer |
| 08/01/2002 | CA2430762A1 Colon cancer marker |
| 08/01/2002 | CA2430746A1 Methods for identifying compounds that modulate disorders related to nitric oxide/cgmp-dependent protein kinase signaling |
| 08/01/2002 | CA2430743A1 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 08/01/2002 | CA2427647A1 Nucleic acid modification enzymes |
| 08/01/2002 | CA2427061A1 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 07/31/2002 | EP1227324A2 Har A polypeptides and nucleic acids and related methods and uses thereof |
| 07/31/2002 | EP1227323A1 Non-A, non-B hepatitis virus antigen, diagnostic methods and vaccines |
| 07/31/2002 | EP1227322A1 Methods of detecting poly(ADP-ribose) polymerase enzymatic activity |
| 07/31/2002 | EP1227320A2 Nucleic acid detection method and apparatus and vessel for detecting nucleic acid |
| 07/31/2002 | EP1227162A2 Sequences and methods for detection of Hepatitis B virus |
| 07/31/2002 | EP1227161A2 Primers, probes and methods for the detection of nucleic acids of hepatitis C viruses |
| 07/31/2002 | EP1227160A1 Compounds modulating sister chromatid separation and method for identifying same |
| 07/31/2002 | EP1227153A2 Serpin from Bifidobacteria |
| 07/31/2002 | EP1227152A1 Bacterial strain and genome of bifidobacterium |
| 07/31/2002 | EP1227146A1 A method for creating endothelial cell dysfunction in cell culture |
| 07/31/2002 | EP1227106A1 Pro-apoptotic proteins and DNA molecules encoding them |
| 07/31/2002 | EP1227084A1 Drug discharge pump inhibitors |
| 07/31/2002 | EP1226871A2 Reactive probe chip and reactive detection sytem |
| 07/31/2002 | EP1226571A1 System and method for programmable illumination pattern generation |
| 07/31/2002 | EP1226546A2 Apparatus and methods for verifying the location of areas of interest within a sample in an imaging system |
| 07/31/2002 | EP1226441A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 07/31/2002 | EP1226437A1 Cantilever sensors and transducers |
| 07/31/2002 | EP1226436A2 Universal fluorescent sensors |
| 07/31/2002 | EP1226433A1 Method for identifying active anti-apoptosis compounds |
| 07/31/2002 | EP1226416A1 Cytological imaging system and method |
| 07/31/2002 | EP1226281A2 Method and compositions for selectively inhibiting amplification of sequences in a population of nucleic acid molecules |
| 07/31/2002 | EP1226280A2 Genetic sequences associated with neural cell proliferation and disease |
| 07/31/2002 | EP1226279A1 Modulation of neuroendocrine differentiation by protein 25.1 |
| 07/31/2002 | EP1226278A1 Methods for identifying and using maintenance genes |
| 07/31/2002 | EP1226277A2 A method for high-density microarray mediated gene expression profiling |
| 07/31/2002 | EP1226276A2 Diagnostic test for cephalic pain |
| 07/31/2002 | EP1226275A2 Detection of nucleic acid heteroduplex molecules by anion-exchange chromatography |
| 07/31/2002 | EP1226274A2 Identification of cells for transplantation |
| 07/31/2002 | EP1226272A2 Double-strand nucleic acid probes and the use thereof |
| 07/31/2002 | EP1226271A2 Dna sequencing method |
| 07/31/2002 | EP1226270A2 Improved assay and reagents therefor |
| 07/31/2002 | EP1226269A2 Reversed-phase hplc assay for plasminogen activators |
| 07/31/2002 | EP1226268A1 New use of the jak-stat system |
| 07/31/2002 | EP1226265A2 Bioproduction of para-hydroxycinnamic acid |
| 07/31/2002 | EP1226262A2 Regeneration |
| 07/31/2002 | EP1226257A2 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
| 07/31/2002 | EP1226255A1 Compositions and methods utilizing dna polymerases |
| 07/31/2002 | EP1226252A2 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO |
| 07/31/2002 | EP1226251A2 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 07/31/2002 | EP1226250A2 Gpcr-kd5 polypeptides and dna sequences thereof |
| 07/31/2002 | EP1226248A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 07/31/2002 | EP1226247A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 07/31/2002 | EP1226243A2 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 07/31/2002 | EP1226231A1 19 human secreted proteins |
| 07/31/2002 | EP1226175A1 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 07/31/2002 | EP1226174A1 Dna molecules encoding l-glutamate-gated chloride channels from schistocerca americana |
| 07/31/2002 | EP1226171A2 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 07/31/2002 | EP1226169A2 Molecular structure of rhd negative locus |
| 07/31/2002 | EP1226153A2 Fluorescent cobalamins and uses thereof |
| 07/31/2002 | EP1226152A2 Regulation of gene expression by neuroleptic agents |
| 07/31/2002 | EP1226151A2 Gene expression directed by a super-psa promoter |
| 07/31/2002 | EP1226150A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 07/31/2002 | EP1226115A1 Novel carbamates and ureas |
| 07/31/2002 | EP1225919A1 Treatment of cancer |
| 07/31/2002 | EP1225909A2 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 07/31/2002 | EP1187934A4 Cell-based assay for screening cox-2 inhibitors |
| 07/31/2002 | EP1064316A4 Immobilization of membrane receptor on hplc |
| 07/31/2002 | EP1021565B1 Z-chromosomal markers derived from chicken (gallus domesticus) and use thereof in chromosomal mapping |
| 07/31/2002 | EP0920630B1 Prion binding proteins and uses thereof |
| 07/31/2002 | EP0912765B1 Determination of analytes by means of two markers |
| 07/31/2002 | EP0883690A4 Polymeric film, assay and method for direct colorimetric detection of analytes |
| 07/31/2002 | EP0817809B1 Homogenous polymer compositions containing silicone for biosensor membranes |
| 07/31/2002 | EP0631633B1 Reaction-based selection for expression of and concentration of catalytic moieties |
| 07/31/2002 | CN1361865A Catalytic anti-factor VIII allo-antibodies |
| 07/31/2002 | CN1361830A Selecting animals for parentally imprinted traits |
| 07/31/2002 | CN1361829A Detection of mutations in genes by specific LNA primers |
| 07/31/2002 | CN1361828A Detection of salmonella enteritidis |